A new trial in South Australia hopes to diagnose Parkinson’s disease earlier by checking dopamine levels in the brain

More than 100,000 Australians are living with Parkinson’s disease, a condition that impacts movement, learning and behaviour. Researchers understand the disease is linked to low dopamine levels in the brain and plan to use that knowledge in a nation-first data-collection trial.

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.